Lim Seah H.

DirectorEmmaus Life Sciences, Inc. (EMMA) · full profile →Form 4 · filed Dec 19, 2023
Net Buying
Open-Market Buys
$31K
Open-Market Sells
$660
Net Open-Market Flow
$30K
Transactions
7
6 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 15, 2023Other(J)4.4M$0.29$1.3M4.6M
Dec 15, 2023Sell(S)6K$0.11$660172K
Sep 5, 2023Buy(P)2K$0.15$255178K
Aug 30, 2023Buy(P)20K$0.15$3K176K
Aug 25, 2023Buy(P)92K$0.27$25K156K
Oct 9, 2022Buy(P)25K$0.11$3K64K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 15, 2023Other(J)240K0

Transaction Codes

J
Other acquisition / disposition
S
Open-market sale
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-059268) within minutes of acceptance. Every field above traces to the original document. Verify it directly: